New Treatments for Lupus by Daniel J. Wallace, MD
Dynamic CT imaging (DCE-CT) in the anti-angiogenic response in Metastatic Renal Cell Carcinoma Prof. C A Cuenod, L Fournier, G Frija Laboratoire de Recherche.
Dr Claes Wilhelmsson Executive Director Research & Development Innovation and the life sciences.
Emerging Issues with Adaptation of Clinical Trial Design in Drug Development* H.M. James Hung Division of Biometrics I, Office of Biostatistics, OPaSS,
Surrogate Markers and its role in the Drug Development Process Aloka G. Chakravarty, Ph.D. Director, Biologics Therapeutics Statistical Staff [email protected].
United states molecular diagnostics market
Diagnose en behandeling van patiënten met een acuut ischemisch CVA
Applications of pharmacokinetics in new drug development,dosage form design & ndds
Effect of New Joinees as Staff Nurses on patient care in Neurosurgery ICU
Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01
Acc2014 14
Modulating PIP2 levels in Cells via PIP5K inhibition
